Literature DB >> 35137873

Incidental findings on lung cancer screening: pictorial essay and systematic checklist.

Diana Penha1,2, Erique Pinto1, Colin Monaghan2, Bruno Hochhegger3,4, Edson Marchiori5,6, Luís Taborda-Barata1,7, Klaus Irion8, Sofia Ravara7,9,10, Hans-Ulrich Kauczor11,12.   

Abstract

Lung cancer screening (LCS) programs are increasing worldwide. Incidental findings (IFs) on LCS are defined as low-dose CT findings unrelated to the primary purpose of identifying lung cancer. Most IFs on LCS are benign and clinically insignificant but are being increasingly recognized, and some require urgent referral for further diagnostic workup. Other findings are expected and are known as smoking-related comorbidities, including COPD, cardiovascular disease, emphysema, and interstitial lung disease, and their diagnosis can have a significant impact on patient prognosis. The purpose of this pictorial essay is to illustrate the most common IFs on LCS, organized by organ. We will discuss the current literature on IFs on LCS, focusing on their prevalence, appropriate communication, and triggering of clinical pathway systems.

Entities:  

Mesh:

Year:  2022        PMID: 35137873      PMCID: PMC8836644          DOI: 10.36416/1806-3756/e20210371

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  28 in total

1.  CT screening for lung cancer: prevalence and incidence of mediastinal masses.

Authors:  Claudia I Henschke; In-Jae Lee; Ning Wu; Ali Farooqi; Arfa Khan; David Yankelevitz; Nasser K Altorki
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

2.  Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee.

Authors:  Brian R Herts; Stuart G Silverman; Nicole M Hindman; Robert G Uzzo; Robert P Hartman; Gary M Israel; Deborah A Baumgarten; Lincoln L Berland; Pari V Pandharipande
Journal:  J Am Coll Radiol       Date:  2017-06-23       Impact factor: 5.532

Review 3.  Incidental Findings on Lung Cancer Screening: Significance and Management.

Authors:  Emily B Tsai; Caroline Chiles; Brett W Carter; Myrna C B Godoy; Girish S Shroff; Reginald F Munden; Mylene T Truong; Carol C Wu
Journal:  Semin Ultrasound CT MR       Date:  2018-03-01       Impact factor: 1.875

4.  Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings Committee.

Authors:  Reginald F Munden; Brett W Carter; Caroline Chiles; Heber MacMahon; William C Black; Jane P Ko; H Page McAdams; Santiago E Rossi; Ann N Leung; Phillip M Boiselle; Michael S Kent; Kathleen Brown; Debra S Dyer; Thomas E Hartman; Eric M Goodman; David P Naidich; Ella A Kazerooni; Lincoln L Berland; Pari V Pandharipande
Journal:  J Am Coll Radiol       Date:  2018-06-22       Impact factor: 5.532

5.  Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography.

Authors:  Michael J Kucharczyk; Ravi J Menezes; Alexander McGregor; Narinder S Paul; Heidi C Roberts
Journal:  Can Assoc Radiol J       Date:  2010-04-10       Impact factor: 2.248

6.  Management of Incidental Pancreatic Cysts: A White Paper of the ACR Incidental Findings Committee.

Authors:  Alec J Megibow; Mark E Baker; Desiree E Morgan; Ihab R Kamel; Dushyant V Sahani; Elliot Newman; William R Brugge; Lincoln L Berland; Pari V Pandharipande
Journal:  J Am Coll Radiol       Date:  2017-05-19       Impact factor: 5.532

7.  Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee.

Authors:  Richard M Gore; Perry J Pickhardt; Koenraad J Mortele; Elliot K Fishman; Jeanne M Horowitz; Claus J Fimmel; Mark S Talamonti; Lincoln L Berland; Pari V Pandharipande
Journal:  J Am Coll Radiol       Date:  2017-09-18       Impact factor: 5.532

8.  ESR/ERS statement paper on lung cancer screening.

Authors:  Hans-Ulrich Kauczor; Anne-Marie Baird; Torsten Gerriet Blum; Lorenzo Bonomo; Clementine Bostantzoglou; Otto Burghuber; Blanka Čepická; Alina Comanescu; Sébastien Couraud; Anand Devaraj; Vagn Jespersen; Sergey Morozov; Inbar Nardi Agmon; Nir Peled; Pippa Powell; Helmut Prosch; Sofia Ravara; Janette Rawlinson; Marie-Pierre Revel; Mario Silva; Annemiek Snoeckx; Bram van Ginneken; Jan P van Meerbeeck; Constantine Vardavas; Oyunbileg von Stackelberg; Mina Gaga
Journal:  Eur Radiol       Date:  2020-02-12       Impact factor: 5.315

9.  Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality.

Authors:  C F Buckens; Y van der Graaf; H M Verkooijen; W P Mali; I Isgum; C P Mol; H J Verhaar; R Vliegenthart; M Oudkerk; C M van Aalst; H J de Koning; P A de Jong
Journal:  Eur Radiol       Date:  2014-09-25       Impact factor: 5.315

10.  Concomitant screening of coronary artery disease and lung cancer with a new ultrafast-low-dose Computed Tomography protocol: A pilot randomised trial.

Authors:  Carlo Gaudio; Alessandra Tanzilli; Mariachiara Mei; Andrea Moretti; Francesco Barillà; Antonio Varveri; Vincenzo Paravati; Gaetano Tanzilli; Antonio Ciccaglioni; Stefano Strano; Massimo Pellegrini; Paolo Barillari; Francesco Pelliccia
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.